Oral Hydralazine Therapy for Chronic Refractory Heart Failure

No abstract is available for this paper.

• Publication year

  1976

• Venue

  Circulation

• Publication date

  1976-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.CIR.54.6.879PMID 825327
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hemodynamic effects of nitroglycerin ointment in congestive heart failure.

  1976cited by this paper
• Hemodynamic improvement with hydralazine in left heart failure

  1976cited by this paper
• Vasodilator Therapy for Chronic Left Ventricular Failure

  1976cited by this paper
• Isosorbide dinitrate for the relief of severe heart failure after myocardial infarction.

  1976cited by this paper
• Hemodynamic and metabolic effects of isosorbide dinitrate in chronic congestive heart failure.

  1975cited by this paper
• Vzasodilator Therapy for Heart Failure

  1975cited by this paper
• Comparative Hemodynamic Effects of Chewable Isosorbide Dinitrate and Nitroglycerin in Patients with Congestive Heart Failure

  1975cited by this paper
• Vasodilator Therapy in Acute Myocardial Infarction: A Comparison of Sodium Nitroprusside and Nitroglycerin

  1975cited by this paper
• Comparative hemodynamic effects of nitroglycerin forms in heart failure

  1975cited by this paper
• Clinical Use of Sodium Nitroprusside in Chronic Ischemic Heart Disease: Effects on Peripheral Vascular Resistance and Venous Tone and on Ventricular Volume, Pump and Mechanical Performance

  1975cited by this paper
• Hemodynamic effects of nitroglycerin in acute myocardial infarction.

  1975cited by this paper
• Editorial: Vasodilator therapy for heart failure.

  1975cited by this paper
• Vasodilator therapy in acute myocardial infarction.

  1975cited by this paper
• Intravenous Nitroglycerin in Acute Myocardial Infarction

  1975cited by this paper
• Use of phentolamine in acute myocardial infarction.

  1974cited by this paper
• Hemodynamic Effects of Orally Administered Isosorbide Dinitrate in Patients with Congestive Heart Failure

  1974cited by this paper
• Enhanced left ventricular performance with phentolamine in acute myocardial infarction.

  1974cited by this paper
• Vasodilator therapy in acute myocardial infarction.

  1974cited by this paper
• Treatment of refractory heart failure with infusion of nitroprusside.

  1974cited by this paper
• Effects of nitroglycerin on left ventricular cavitary size and cardiac performance determined by ultrasound in man.

  1974cited by this paper
• Hemodynamic and Metabolic Responses to Vasodilator Therapy in Acute Myocardial Infarction

  1973cited by this paper
• Beneficial Effects of Vasodilator Agents in Severe Mitral Regurgitation Due to Dysfunction of Subvalvar Apparatus

  1973cited by this paper
• Late toxicity to hydralazine resembling systemic lupus erythematosus or rheumatoid arthritis.

  1973cited by this paper
• Vasodilator Therapy for Heart Failure: The Influence of Impedance on Left Ventricular Performance

  1973cited by this paper
• Treatment of essential hypertension with combined vasodilation and beta-adrenergic blockade.

  1972cited by this paper
• Thermodilution cardiac output determination with a single flow-directed catheter.

  1972cited by this paper
• Use of Sublingual Nitroglycerin in Congestive Failure following Acute Myocardial Infarction

  1972cited by this paper
• Improved left ventricular function during nitroprusside infusion in acute myocardial infarction.

  1972cited by this paper
• Measurement of blood flow by thermodilution.

  1972cited by this paper
• From cardiac catheterization data to hemodynamic parameters

  1972cited by this paper
• Phentolamine for vasodilator treatment of severe heart-failure.

  1971cited by this paper
• Actions of the nitrites on the peripheral circulation and myocardial oxygen consumption: significance in the relief of angina pectoris.

  1971cited by this paper
• Phentolamine and cardiovascular performance.

  1969cited by this paper
• The Effects of Nitroglycerin and Amyl Nitrite on Arteriolar and Venous Tone in the Human Forearm

  1965cited by this paper
• A study of the mechanism of the hemodynamic effects of hydralazine in man.

  1963cited by this paper
• Hemodynamic effects of 1-hydrazinophthalazine in patients with arterial hypertension.

  1955cited by this paper
• Studies on hydralazine; evidence for a peripheral site of action.

  1954cited by this paper
• Hydrallazine (apresoline) hydrochloride; pharmacological observations and clinical results in the therapy of hypertension.

  1953cited by this paper
• The Hemodynamic Effects of Hypotensive Drugs in Man: IV. 1‐Hydrazinophthalazine

  1953cited by this paper
• Cardiovascular and renal adjustments to a hypotensive agent (l'hydrazinophthalazine: Ciba BA-5968: apresoline).

  1952cited by this paper

• Venture Capital and Entrepreneurship in Heart Failure: A Review for Cardiologists

  2025cites this paper
• Splanchnic nerve modulation in heart failure: mechanistic overview, initial clinical experience, and safety considerations

  2021cites this paper
• Thermodynamic and Kinetic Studies of the Radical Scavenging Behavior of Hydralazine and Dihydralazine: Theoretical Insights.

  2020cites this paper
• Substitution effects on the antiradical activity of hydralazine: a DFT analysis

  2020cites this paper
• Hydralazine derivative of aldehyde: A new type of [M - H]+ ion formed in electrospray ionization mass spectrometry.

  2019cites this paper
• Electrocardiographic Changes Following Acute Hydralazine Overdose.

  2019cites this paper
• Pfeetof EMinonCardiac Performance in Congestive Heart Failure

  2017cites this paper
• Independence of oxygen consumption and systemic oxygen transport in patients with either stable pulmonary hypertension or refractory left ventricular failure.

  2015cites this paper
• Epigenetics in cancer : basic and translational aspects.

  2012cites this paper
• The Role of Vasodilator Therapy in the Treatment of Severe Chronic Heart Failure

  2012cites this paper
• The Application of Delivery Systems for DNA Methyltransferase Inhibitors

  2011cites this paper
• Hydralazine in chronic CHF.

  2009cites this paper
• Central and renal circulation, renin and aldosterone in plasma during prazosin treatment in essential hypertension.

  2009cites this paper
• Acute hemodynamic and long-term clinical effects of prazosin in the treatment of chronic congestive heart failure.

  2009cites this paper
• Management of severe chronic CHF with oral pirbuterol.

  2009cites this paper
• Captopril - an oral angiotensin-converting enzyme inhibitor in CHF.

  2009cites this paper
• Sustained effect of hydralazine in long term treatment of CHF.

  2009cites this paper
• Haemodynamic effects of prazosin in CHF.

  2009cites this paper
• Effects of Bed Rest and Prazosin in Congestive Heart Failure

  2009cites this paper
• Hemodynamic and metabolic effects of vasodilators, nitrates, hydralazine, prazosin and captopril in chronic ischemic heart failure.

  2009cites this paper
• [Low-dose enalapril as additional medication in severe chronic heart failure].

  2008cites this paper
• The Comparison of The Efficacy and The Confidence of The Vasodilator Therapy With Felodipine And Lisinopril in Chronic , Moderate to Severe Aortic Regurgitation

  2007cites this paper
• Is There a Drug of Choice for Vasodilafor Therapy in Pafienfs with Refractory Heart Failure ?

  2005cites this paper
• Low-dose enalapril in severe chronic heart failure

  2005cites this paper
• Vasodilator therapy without converting-enzyme inhibition in congestive heart failure—Usefulness and limitations

  2005cites this paper
• Hemodynamic Effects of Oral Pirbuterol

  2005cites this paper
• Pharmacological options for acute heart failure syndromes: current treatments and unmet needs

  2005cites this paper
• THERAPY AND PREVENTION

  2005cites this paper
• Hemodynamic Effects of Hydralazine in Infants with a Large Ventricular Septal Defect

  2005cites this paper
• BiDil® (isosorbide dinitrate and hydralazine hydrochloride) Tablets

  2005cites this paper
• Arterial Dilators in Mitral Regurgitation: Effects

  2005cites this paper
• CONGESTIVE HEART FAILURE Enalapril in patients with chronic heart failure : a placebo-controlled , randomized , double-blind study

  2005cites this paper
• Acute and Long-term Effects of Vasodilator Therapy

  2005cites this paper
• The acute haemodynamic effects of quinapril, a new non-sulfhydryl angiotensin converting enzyme inhibitor, in patients with severe congestive cardiac failure

  2004cites this paper
• Clinical pharmacology of tolmesoxide in refractory heart failure

  2004cites this paper
• Therapie der Herzinsuffizienz

  2004cites this paper
• Pharmacokinetics of oral hydralazine in chronic heart failure

  2004cites this paper
• WILLIAM WATTS PARMLEY, MD: A Conversation With the Editor*

  2002cites this paper
• Congestive Heart Failure

  2002cites this paper
• Consensus recommendations for the management of chronic heart failure. On behalf of the membership of the advisory council to improve outcomes nationwide in heart failure.

  1999cites this paper
• Effects of hydralazine on renal sympathetic nerve activity in normal and congestive heart failure rats.

  1997cites this paper
• Heart failure therapy in evolution.

  1996cites this paper
• Suppressing sympathetic activation in congestive heart failure. A new therapeutic strategy.

  1995cites this paper
• Beneficial effects of a single dose of quinapril on left ventricular performance in chronic mitral regurgitation.

  1994cites this paper
• Effect of medications on cardiac output

  1993cites this paper
• Why does pulmonary venous pressure rise after onset of LV dysfunction: a theoretical analysis.

  1993cites this paper
• Vasodilator therapy for congestive heart failure. Lessons from mortality trials.

  1993cites this paper
• Cardiac Output and Regional Flow in Health and Disease

  1993cites this paper
• How should physicians view heart failure? The philosophical and physiological evolution of three conceptual models of the disease.

  1993cites this paper
• Effect of direct vasodilation with hydralazine versus angiotensin-converting enzyme inhibition with captopril on mortality in advanced heart failure: the Hy-C trial.

  1992cites this paper
• Exacerbation of Congestive Heart Failure Secondary to Moricizine

  1992cites this paper
• [Evaluation of the hemodynamic effects of the long-acting peripheral vasodilator flosequinan in patients with chronic heart failure].

  1991cites this paper
• Treatment considerations for the hypertensive patient over age 55

  1991cites this paper
• Does the magnitude of mitral regurgitation determine hemodynamic response to vasodilation in chronic congestive heart failure?

  1991cites this paper
• Direct Measurement of Aortic and Vena Caval Flow to Evaluate the Effect of Vasodilators in Experimental Acute mitral regurgitation

  1990cites this paper
• Review: therapeutic concepts of congestive heart failure.

  1990cites this paper
• Hemodynamic studies-their uses and limitations

  1989cites this paper
• Importance of Venodilatation in Prevention of Left Ventricular Dilatation After Chronic Large Myocardial Infarction in Rats: A Comparison of Captopril and Hydralazine

  1989cites this paper
• Clinical Pharmacokinetics and Therapeutic Use of Hydralazine in Congestive Heart Failure

  1989cites this paper
• Low-dose enalapril in severe chronic heart failure.

  1989cites this paper
• Vasodilator therapy without converting-enzyme inhibition in congestive heart failure—Usefulness and limitations

  1989cites this paper
• Congestive heart failure--advances in treatment. Hemodynamic studies--their uses and limitations.

  1989cites this paper
• Pharmacological Actions of DPN 205–734, a Novel Cardiotonic Agent

  1988cites this paper
• Vasodilator therapy in chronic congestive heart failure.

  1988cites this paper
• Therapeutics in Cardiology

  1988influential citation
• Congestive cardiac failure: advances in management

  1988cites this paper
• Direct effects of hydralazine on cardiac contractile function, haemodynamics, and myocardial energetics in isolated myocardium.

  1988cites this paper
• Management of Congestive Heart Failure in the Elderly

  1988cites this paper
• Vasodilator Therapy of Chronic Aortic Regurgitation

  1988cites this paper
• Vasodilators in the Treatment of Congestive Heart Failure

  1988cites this paper
• The hypertensive patient with concomitant cardiovascular disease.

  1988cites this paper
• Isradipine improves cardiac function in congestive heart failure

  1988cites this paper
• Congestive heart failure.

  1988cites this paper
• [Characteristics of the pharmacotherapy of chronic heart failure under high-altitude conditions].

  1988cites this paper
• [Therapy of chronic heart failure with angiotensin-converting enzyme inhibitors].

  1988cites this paper
• [Treatment of chronic cardiac failure with cadralazine. Short- and medium-term results].

  1987cites this paper
• Vasodilators as first-line therapy for congestive heart failure: a comparative hemodynamic study of hydralazine, digoxin, and their combination.

  1987cites this paper
• Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

  1987cites this paper
• Static exercise with congestive heart failure and the response to vasodilating drugs.

  1987cites this paper
• [Treatment of patients with chronic nonspecific lung diseases complicated by cor pulmonale].

  1987cites this paper
• Hemodynamic effects of PN 200-110 (isradipine) in congestive heart failure.

  1987cites this paper
• Prazosin for vasodilator treatment of acute pulmonary oedema due to scorpion sting.

  1987cites this paper
• Hemodynamic effects of BTS 49465, a new long-acting systemic vasodilator drug, in patients with severe congestive heart failure.

  1987cites this paper
• Beneficial Effects of the Calcium Antagonist PN 200–110 in Patients with Congestive Heart Failure

  1987cites this paper
• Medical treatment of congestive heart failure: where are we now?

  1987cites this paper
• Management of hypertension in patients with concomitant diseases.

  1987cites this paper
• Congestive heart failure.

  1986cites this paper
• Vasodilator therapy.

  1986cites this paper
• Cadralazin, eine neue vasodilatierende Substanz. Hämodynamische Akutwirkungen bei Patienten mit chronischer Herzinsuffizienz

  1986cites this paper
• [Hemodynamic effects of an alpha-blocking vasodilator in cardiac insufficiency caused by left-right shunt in children].

  1986cites this paper
• Correlation between effects of hydralazine on force and on the adenyl cyclase system of ventricular myocardium in dogs and cats.

  1986cites this paper
• Nitrates as Adjuvant Therapy for Chronic Congestive Heart Failure

  1986cites this paper
• The Treatment of Heart Failure

  1986cites this paper
• Langzeitwirkung von Propyldazin bei chronischer Herzinsuffizienz

  1986cites this paper
• Enhanced myocardial necrosis induced in rats by the combined administration of hydralazine and prenalterol

  1986cites this paper
• Effects of eating on cardiac performance in congestive heart failure.

  1986cites this paper
• Comparative Immediate Hemodynamic and Hormonal Effects of Amrinone and Captopril in Patients with Severe Chronic Heart Failure

  1986cites this paper
• Hydralazine and Its Metabolites: In Vitro and In Vivo Activity in the Rat

  1986cites this paper
• [Role of vasodilator agents in the complex treatment of circulatory insufficiency in patients with ischemic heart disease].

  1986cites this paper
• Wirkungsabschwächung bei der Langzeittherapie der chronischen Herzinsuffizienz mit Dihydralazin

  1986cites this paper